# Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas

> **NCT00474994** · PHASE2 · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 53 (actual)

## Conditions studied

- Adult Malignant Fibrous Histiocytoma of Bone
- Desmoid Tumor
- Endometrial Cancer
- Ovarian Cancer
- Sarcoma
- Small Intestine Cancer

## Interventions

- **DRUG:** sunitinib malate

## Key facts

- **NCT ID:** NCT00474994
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04
- **Primary completion:** 2010-11
- **Final completion:** 2010-11
- **Target enrollment:** 53 (ACTUAL)
- **Last updated:** 2016-01-20

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00474994

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00474994, "Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas". Retrieved via AI Analytics 2026-07-28 from https://api.ai-analytics.org/clinical/NCT00474994. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*